You are here: Biosafe SA » Versatility of the Sepax technology » Stem cell banking » Europe, Middle East, Africa » Protocols
Dear visitor, our website is optimized for version 9 of Internet Explorer. Click here to download it.Thank you for your understandingBiosafe Group SA.
Processing of umbilical cord blood based on a sedimentation agent to isolate total nucleated cells.
Processing of umbilical cord blood to isolate total nucleated cells without any additive.
Plasma depletion of umbilical cord blood.
Volume reduction of peripheral blood stem cell product.
Copyright 2013 - Biosafe Group SA
Copyright 2013 - Biosafe Group SA